So, the Susan Komen Foundation has hired a big-hitter PR firm. And not just any PR firm, either.
Now, Komen is assessing the damage, and it’s using a consulting firm founded by two former Democratic strategists. Penn Schoen Berland (PSB), the firm Komen hired to help determine how badly the crisis hurt its reputation, is founded by former Democratic strategists Mark Penn and Doug Schoen.
The goal here seems obvious. Komen’s recent bout of ballistic podiatry cost it massive amounts of support among people who believe that women’s health shouldn’t be held captive to a reactionary, partisan social conservative agenda. The foundation has accurately understood that this means it needs people from the center and points left in order to thrive. Or, at this point, survive. So they go out and hire … Mark Penn.
Wait, what? Continue reading Komen hires the wrong PR firm, missing the boat once again (and some thoughts on PR Daily’s coverage of the story)
The Komen Foundation VP at the center of the Planned Parenthood firestorm, Karen Handel, has resigned.
A few days ago I predicted on Facebook that she’d be gone within a week, but then retracted the prediction when I learned more about the heavy-Right political leanings of the rest of the board (and the involvement of Ari Fleischer in their strategy development).
On Friday, just before America took its collective brain offline for Super Bowl Weekend, Komen offered up a fake apology that encouraged the public to believe that it had changed its mind and was going to continue funding Planned Parenthood after all, even though its release actually said nothing of the sort. It isn’t clear how many average citizens the ploy fooled, but as I explained on Saturday, it sure as hell clowned the copy desk editors of just about every major news outlet in the country. Continue reading Komen VP resigns; an important first step, but a long road to reconciliation remains
Read. The language. Closely.
Contrary to what Komen’s highly-paid PR crisis hacks and gullible headline writers at newsdesks around the nation would ask you to believe, The Susan G. Komen Foundation does NOT promise to fund Planned Parenthood in the future. They promise to let PP APPLY for grants in the future. Applying and receiving are different things, as anyone who ever applied and got rejected for a job ought to know. Continue reading Komen Foundation pretends to change its mind. One corporate communications executive wonders: is the public stupid enough to buy it?
That headline probably sounds like the dumbest thing anybody ever said, doesn’t it? In truth, though, I mean it as a profound compliment. Let me explain why.
Today is LiveStong Day and it’s also Susan Komen Race for the Cure Day here in Denver. Earlier this morning, roughly 50,000 people participated in the Race for the Cure over at Pepsi Center, and annually there are about 130 such races worldwide. For context, here’s the Wiki intro.
Since its inception in 1982, Komen has invested nearly $2 billion for breast cancer research, education, advocacy, health services and social support programs in the U.S., and through partnerships in more than 50 countries. Continue reading Why I envy people with cancer
Every once in awhile I come across unrelated stories that somehow associate themselves in my mind. Take these, for instance:
First, I hope you saw Lex’s tribute to Starchild (given name, Gary Shider), he of P-Funk fame. As Lex notes, Shider experienced problems where the cost of fighting the cancer that killed him was concerned.
Second, another American music icon, Alex Chilton, passed away earlier this year. Continue reading ArtSunday: Let the musicians die
Part three in a series.
In an age and a culture dominated by scientism, the word â€œsampleâ€ tends to invoke the adjectival â€œrepresentative,â€ and I cannot begin to imagine culling a meaningful representative sample from LIFEâ€™s 400-plus issues. Still, it seems important to devote a few pages to what happened with LIFE and technology between the Fort Peck Dam and Apollo 17. I will center this discussion on innovations and events that, from our perspective here at the end of the century, appear to have left significant marks on history.
The Medical Morality Play
LIFEâ€™s coverage of medical technology began early and covered, through the decades, the research, development, and application of treatments for a variety of diseases and disorders afflicting humanity. Continue reading War and Postwar: a look at LIFE and technology